long intergenic non-protein coding RNA 1055Genealiases: []
Q-omics provides the consensus-scored LINC01055 profile across patient tissues and cancer cell-line models. LINC01055 expression is associated with patient survival in 22 of 34 cancer types, with the highest sampling consensus in SKCM. Among the 18 cancer types available for tumor–normal comparison, LINC01055 is differentially expressed in 8, with the highest sampling consensus in KIRC. Additionally, LINC01055 RNA expression shows 8,002 significant gene co-expression associations, with the highest sampling consensus in PAAD. Together, these results highlight SKCM, KIRC, and PAAD as cancer lineages where LINC01055 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC01055 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC01055 survival associations across molecular data types. LINC01055 RNA expression shows survival associations in the most cancer types (22). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC01055 RNA expression–survival associations across cancer types. High LINC01055 expression shows favorable associations in SKCM, HNSC, BRCA, STAD, COAD and LGG. The SKCM Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify SKCM as the clearest survival context for LINC01055 RNA expression.
This table summarizes LINC01055 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 8. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC01055. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC01055 shows lower tumor expression in KIRC, KIRP, COAD, KICH, READ and BRCA. The KIRC box plot shows higher LINC01055 RNA expression in normal versus tumor tissue (log2 FC = −4.295, t-test p < 0.001).
This table shows molecular features associated with LINC01055 in patient tissues and cancer cell lines. In patient samples, LINC01055 shows the broadest associations at the RNA and protein expression levels, with PAAD recurring as the lineage with the largest associated feature set.
